CD47 and cancer: Both CGs decreased the number of remaining cells at the nanomolar level, and the percentage of remaining cancer cells decreased dramatically when 50 nM ouabain or 200 nM digoxin was combined with CD47 antibody (Figure 1C; Figure S1A, Supporting Information).